Cancer Research
Multi-Omics in Cancer Research
Mass spectrometry quantifies proteins and PTMs across samples. Our proteomic services help discover actionable therapeutic targets and response predictors.
NGS Applications
Whole Genome Sequencing
Whole genome sequencing empowers cancer researchers to comprehensively study genetic mutations and identify new therapeutic targets, propelling breakthroughs in precision oncology.
Whole Exome Sequencing
By analyzing the protein-coding regions of DNA, whole exome sequencing enables cancer researchers to efficiently detect mutations in genes that drive tumor growth and metastasis, expediting the development of targeted therapies.
Epigenetics
Epigenetics services enable cancer researchers to identify chemical modifications to DNA that control gene expression, uncovering new mechanisms driving tumor initiation and progression for advanced drug targeting.
RNA Sequencing
RNA sequencing allows cancer researchers to analyze gene expression levels and identify biomarkers involved in tumor progression and metastasis, providing critical genomic insights to develop more effective diagnostic tests and therapies.
Metagenomics
Metagenomics empowers cancer researchers to analyze the collective microbiome genome, helping identify new bacterial drivers of tumor growth and progression for the development of improved probiotic therapies.
Single Cell Sequencing
Single-cell sequencing allows cancer researchers to profile individual cells, revealing tumor heterogeneity and identifying diverse drug-resistant subclones to guide more targeted and effective therapeutic strategies.
Stereo-seq
Life development is a dynamic process in which multiple cell types interact with each other in a three-dimensional space. Therefore, spatial analysis of cell types and their interactions is the basis of developmental research. Spatial transcriptome technology -- Stereo-seq, can map the complex interactions of various cell types during developmental stages at the molecular level, profoundly advancing the field of development with unprecedented precision and complexity.
Mass Spectrometry Applications
Proteomics
Mass spectrometry proteomics services enable cancer researchers to detect biomarkers, comprehend signaling pathways, and identify therapeutic targets by identifying and quantifying proteins and peptides in biological samples.
Metabolomics
Mass spectrometry metabolomics enables cancer researchers to elucidate metabolic pathways, identify diagnostic biomarkers, and reveal the systemic effects of malignancy by profiling the complete complement of small molecule metabolites in biological samples.
Multi-omics
By integrating proteomics, metabolomics, and genomics data from biological samples, mass spectrometry multi-omics services allow cancer researchers to develop a systems-level comprehension of tumors and identify novel diagnostic, prognostic, and therapeutic targets.
If you want more information?
Consult us now!